Načítá se...
Carotid dosimetry after re-irradiation with (131)Cs permanent implant brachytherapy in recurrent, resected head and neck cancer
PURPOSE: Permanent seed implant cesium-131 ((131)Cs) brachytherapy provides highly localized radiation for patients with recurrent head and neck cancer (HNC), who may be ineligible for external beam radiation therapy due to a high-risk of toxicity. As carotid blowout is a concern in the setting of r...
Uloženo v:
| Vydáno v: | J Contemp Brachytherapy |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Termedia Publishing House
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6701389/ https://ncbi.nlm.nih.gov/pubmed/31447900 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/jcb.2019.86298 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|